Complete Story


Applied Announces New FDA Drug Reporting Service


Applied Home Healthcare Equipment, a long-trusted resource for oxygen filling, technical and regulatory support for DME and HME providers, has announced the launch of their new drug reporting service.

This new service provides drug manufacturers (transfillers) peace of mind knowing they are meeting the FDAs new requirement to report the amount of medical oxygen filled and released to patients annually. The reported data will improve FDA’s visibility into the drug supply chain and will help the agency identify, prevent, and mitigate drug shortages.

Reports for calendar year 2020 should be submitted no later than February 15, 2022, and reports for calendar year 2021 should be submitted no later than May 16, 2022.

Jim Christ, General Manager of Applied Home Healthcare Equipment said “The new drug reporting service we’re offering takes the worry out of annual reporting for our transfillers. Many providers are confused on how to and what to provide to the FDA, so we are offering this service to make it as easy as possible.”   

The new drug reporting service will expand on the FDA registration and drug listing service currently offered by Applied’s FDA registration department. The new drug reporting service is offered for 2020, 2021, or both years for a discounted price.

Founded in 1993, Applied Home Healthcare Equipment is committed to helping providers and dealers get the information and tools they need to be successful in the oxygen business.

** Applied is a Champion Level OAMES Associate member actively involved in the association supporting Ohio's HME provider community year round.

Printer-Friendly Version